Russia still expects to ink deal with Astra Zeneca for Covid-19 vaccine
Russia still expects to conclude a deal with AstraZeneca to manufacture the Covid-19 vaccine that it is working on with Oxford University.
AstraZeneca
10,988.00p
17:15 09/01/25
2.18%
234.00p
FTSE 100
8,319.69
16:49 09/01/25
n/a
n/a
FTSE 350
4,563.23
16:44 09/01/25
n/a
n/a
FTSE All-Share
4,517.93
17:05 09/01/25
n/a
n/a
GSK
1,349.50p
17:15 09/01/25
-0.77%
-10.50p
Pharmaceuticals & Biotechnology
20,778.26
16:44 09/01/25
1.32%
271.63
In an interview with Reuters, Kirill Dmitriev, the head of the Russian Direct Investment Fund, said he still expected such a deal to go through, despite allegations that Moscow had tried to steal research data by hacking into the computer networks of scientific institutes around the world.
British intelligence ascribed a 95% probability to the chance of the hackers being linked to the Russian state.
Indeed, such a deal might be announced later on Friday, he said.
"There's nothing that needs to be stolen [...] It's all going to be given to Russia."